⌘K

Login Start Free

Home/Filings/4/0000950120-06-000777

4//SEC Filing

KASH PETER M 4

Accession 0000950120-06-000777

CIK 0000050710other

View on SEC.gov Company Profile

Filed

Dec 11, 7:00 PM ET

Accepted

Dec 12, 4:32 PM ET

Size

17.3 KB

Accession

0000950120-06-000777

Insider Transaction Report

Form 4

Period: 2006-12-08

JAVELIN PHARMACEUTICALS, INCAMEX:JAV

Director

Transactions

Other
Stock Options
2006-12-08$4.05/sh−26,575$107,629→ 252,835 total
Exercise: $4.05→ Common Stock (0 underlying)
Other
Stock Options
2006-12-08$1.96/sh+30,552$59,882→ 169,410 total
Exercise: $1.96→ Common Stock (30,552 underlying)
Other
Stock Options
2006-12-08$3.87/sh+87,116$337,139→ 87,116 total
Exercise: $3.87→ Common Stock (87,116 underlying)
Other
Stock Options
2006-12-08$2.70/sh+35,000$94,500→ 204,410 total
Exercise: $2.70→ Common Stock (35,000 underlying)
Other
Stock Options
2006-12-08$5.36/sh+51,742$277,337→ 138,858 total
Exercise: $5.36→ Common Stock (51,742 underlying)
Other
Stock Options
2006-12-08$4.05/sh+48,425$196,121→ 252,835 total
Exercise: $4.05→ Common Stock (48,425 underlying)

Footnotes (2)

[F1]Upon the resignation of Peter M. Kash as a Director of Javelin Pharmaceuticals, Inc., stock options previously granted to Mr. Kash under the 2005 Omnibus Stock Incentive Plan for an aggregate of 252,835 shares of Common Stock either were or became fully vested and exercisable in whole or in part for a period of 18 months (June 8, 2007) from the date of resignation.
[F2]The balance of options awarded to Mr. Kash for 26,575 shares of Common Stock were terminated upon such resignation.

Documents

1 file

4
kash-javform4_1212ex.xmlPrimary

Issuer

JAVELIN PHARMACEUTICALS, INC

CIK 0000050710

Entity typeother

Related Parties

1

filerCIK 0001253023

Filing Metadata

Form type: 4
Filed: Dec 11, 7:00 PM ET
Accepted: Dec 12, 4:32 PM ET
Size: 17.3 KB

View on SEC.gov